Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
48.16
-1.15 (-2.33%)
Aug 1, 2025, 2:45 PM CST
SHA:688076 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 490.68 | 404.39 | 162.94 | 129.11 | 115.39 | 123.44 | Upgrade |
Depreciation & Amortization | 209.29 | 209.29 | 135.55 | 99.96 | 84.77 | 70.71 | Upgrade |
Other Amortization | 7.73 | 7.73 | 4.61 | 4.72 | 4.25 | 6.41 | Upgrade |
Loss (Gain) From Sale of Assets | -0.5 | -0.5 | -0.18 | -18.89 | -0.06 | 3.82 | Upgrade |
Asset Writedown & Restructuring Costs | 9.7 | 9.7 | 15.3 | 0.45 | 2.31 | 0.3 | Upgrade |
Loss (Gain) From Sale of Investments | 1.72 | 1.72 | -3.16 | -19.98 | -3.22 | -6.43 | Upgrade |
Provision & Write-off of Bad Debts | 20.62 | 20.62 | 5.11 | 5.87 | 1.65 | 1.84 | Upgrade |
Other Operating Activities | 38.76 | 58.16 | 49 | 29.63 | 15.44 | 15.8 | Upgrade |
Change in Accounts Receivable | -348.97 | -348.97 | -126.49 | -145.04 | -45.88 | -42.32 | Upgrade |
Change in Inventory | -243.29 | -243.29 | -82.58 | -111.74 | -87.63 | -73.43 | Upgrade |
Change in Accounts Payable | 291.17 | 291.17 | 180.38 | 58.34 | 75.82 | 30.26 | Upgrade |
Change in Other Net Operating Assets | 32.63 | 32.63 | 23.3 | 1.71 | 8.77 | 7.02 | Upgrade |
Operating Cash Flow | 467.01 | 400.12 | 350.21 | 29.29 | 180.75 | 141.38 | Upgrade |
Operating Cash Flow Growth | 64.45% | 14.25% | 1095.59% | -83.79% | 27.84% | 206.44% | Upgrade |
Capital Expenditures | -1,276 | -1,090 | -660.64 | -438.36 | -233.36 | -111.28 | Upgrade |
Sale of Property, Plant & Equipment | 3.96 | 3.98 | 1.53 | 0.06 | 0.34 | 11.46 | Upgrade |
Divestitures | - | - | - | 13.12 | - | 17 | Upgrade |
Investment in Securities | 100.01 | -308 | -6 | -25.95 | -7 | -80.76 | Upgrade |
Other Investing Activities | 1.41 | 0.95 | 2.9 | 1.39 | 3.09 | 0.41 | Upgrade |
Investing Cash Flow | -1,171 | -1,393 | -662.21 | -449.74 | -236.93 | -163.18 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 242.68 | - | Upgrade |
Long-Term Debt Issued | - | 1,698 | 1,146 | 388.99 | - | 291.38 | Upgrade |
Total Debt Issued | 1,713 | 1,698 | 1,146 | 388.99 | 242.68 | 291.38 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -422.79 | - | Upgrade |
Long-Term Debt Repaid | - | -901.76 | -454.73 | -129.65 | -4.11 | -242.83 | Upgrade |
Total Debt Repaid | -950.8 | -901.76 | -454.73 | -129.65 | -426.91 | -242.83 | Upgrade |
Net Debt Issued (Repaid) | 762.18 | 796.43 | 691.05 | 259.34 | -184.23 | 48.55 | Upgrade |
Issuance of Common Stock | 22.98 | 22.98 | - | - | 762.63 | - | Upgrade |
Common Dividends Paid | -124.48 | -118.75 | -57.61 | -40.57 | -6.04 | - | Upgrade |
Dividends Paid | -124.48 | -118.75 | -57.61 | -40.57 | -6.04 | - | Upgrade |
Other Financing Activities | 99.48 | 99.1 | -1.54 | 18.15 | -37.47 | -9.04 | Upgrade |
Financing Cash Flow | 760.16 | 799.75 | 631.9 | 236.91 | 534.89 | 39.5 | Upgrade |
Foreign Exchange Rate Adjustments | 7.93 | 8.34 | -3.21 | -0.82 | -1.58 | -7.73 | Upgrade |
Net Cash Flow | 64.44 | -184.98 | 316.69 | -184.35 | 477.13 | 9.98 | Upgrade |
Free Cash Flow | -809.03 | -690.01 | -310.43 | -409.07 | -52.61 | 30.1 | Upgrade |
Free Cash Flow Margin | -44.10% | -42.47% | -30.04% | -62.81% | -8.17% | 5.31% | Upgrade |
Free Cash Flow Per Share | -2.62 | -2.24 | -1.03 | -1.38 | -0.20 | 0.13 | Upgrade |
Cash Interest Paid | - | - | - | - | - | 11.63 | Upgrade |
Cash Income Tax Paid | - | 18.56 | 8.2 | -29.3 | -11.18 | -7.26 | Upgrade |
Levered Free Cash Flow | -833.68 | -856.88 | -374.23 | -441.9 | -133.86 | -70.96 | Upgrade |
Unlevered Free Cash Flow | -807.87 | -835.17 | -364.18 | -436.11 | -130.04 | -63.69 | Upgrade |
Change in Net Working Capital | 138.75 | 281.18 | -14.62 | 147.75 | 64.68 | 118.16 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.